Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-09-28

FDA Approved: DUODOTE — Original Application (Meridian Medical Technologies LLC)

View source ↗

Summary

FDA approved DUODOTE, a dual-auto-injector containing atropine and pralidoxime chloride, for emergency treatment of organophosphate poisoning; the product is in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUODOTE (Atropine and Pralidoxime chloride)

Snippet

ORIG AP for DUODOTE (ATROPINE AND PRALIDOXIME CHLORIDE)